Vaishali Pharma Limited — Board/Management Information 2021

Jul 10, 2021

Vaishali Pharma Ltd.

CORPORATE & REGISTERED OFFICE: 706-709, 7th Floor, Aravali Business Centre, R. C. Patel Road, Off. Sodawala Lane, Borivali (West), Mumbai-400 092. Tel.: +91-22-4217 1819 E-mail: sales@vaishalipharma.com CIN-L52310MH2008PLC181632

10th July, 2021

$To.$ National Stock Exchange of India Limited Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400 051

Stock Code: VAISHALI

SUB: OUTCOME OF MEETING OF THE BOARD OF DIRECTORS OF VAISHALI PHARMA LIMITED ("THE COMPANY") IN TERMS OF REGULATION 30 OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015, AS AMENDED

Dear Sir/Madam,

Pursuant to the provisions of Schedule III, Part A, Sub-regulation 4 of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that a meeting of the Board of Directors of the Company was held today i.e. on Saturday, 10th July, 2021, which commenced at 04:30 p.m. and concluded at 05:30 pm at the Registered Office of the Company located at 706 to 709, 7th Floor, Aravali Business Center, R.C. Patel Road, Off Sodawala Lane, Borivalli (West), Mumbai - 400092, inter-alia, transacted the following items of the business:

1. Approved the Increase of Authorised Share Capital of the Company and consequent alteration of Capital Clause of Memorandum of Association of the Company:

Subject to approval of the Shareholders, the board has approved the increase in Authorised Share Capital of the Company from existing Rs. 11,00,00,000 (Rupees Eleven Crores only) divided into 1,10,00,000 (One Crore Ten Lakhs) Equity Shares of face value of Rs. 10/ - (Rupees Ten only) each to Rs. 22,00,00,000 (Rupees Twenty-Two Crores Only) divided into 2,20,00,000 (Two Crores Twenty Lakhs) Equity Shares of face value of Rs. 10/- (Rupees Ten only) each by creation of additional 1,10,00,000 (One Crore Ten Lakhs) equity shares of face value of Rs.10/- each ranking pari passu in all respect with the, existing equity shares of the company

The present clause be altered as follows:

V. The Authorised Share Capital of the Company is Rs. 22,00,00,000/- (Rupees Twenty Two Crore only) divided into 2,20,00,000 (Two Crores Twenty Lakhs) equity shares of Rs. 10/- (Rupees Ten only), with the power to the Board to divide the shares in the capital for the time being into several classes, to decide on the extent of variation in such rights and to classify and re-classify, from time to time, such shares into any class of shares and to attach thereto respectively such preferential, qualified or special rights, privileges or conditions as may be determined by or in accordance the provisions of

Page 1 of 2

Vaishali Pharma Ltd.

CORPORATE & REGISTERED OFFICE: 706-709 7th Floor, Aravali Business Centre. R. C. Patel Road. Off. Sodawala Lane, Borivali (West), Mumbai-400 092. Tel.: +91-22-4217 1819 E-mail: sales@vaishalipharma.com CIN - L52310MH2008PLC181632

the Act, and to vary, modify or abrogate any such rights, privileges or conditions in such manner as may for the time being be provided by the relevant provisions of the Act.

1. Approved the Raising of Funds by way of Offer and Issue of Equity Shares to the Existing Shareholders of the company on a Rights Basis (Rights Issue).

The Board has constituted a Rights Issue Committee of Directors for the above purpose and has authorised the Committee to determine the terms of the Rights Issue including the quantum of issue, rights entitlement ratio, issue price, issue size, book closure or record date, entitlement timing of the issue, etc., and to decide any other matters relating to the Right Issue. Such details shall be informed and/or announced in due course as and when decided or required, as per applicable statutory provisions and depending upon the market conditions. The above proposal to issue of shares shall be subject to necessary approvals, confirmations and consents as may be necessary and in compliance with applicable law including the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013 and the Rules made there under and as amended.

• 1. Approved the draft Notice Convening Extra-Ordinary General Meeting of the Company.
• 1. Approved the Closure of Share Transfer Book for the purpose of forthcoming Extra Ordinary General Meeting.
• 1. Approved the Appointment of Scrutinizer to oversee the E-voting process of the Company at the Extra-Ordinary General Meeting.
• 1. Approved the appointment of Mr. Pratik Vikram Jakhela (DIN: 07726752) as an Additional Independent Director of the Company.
• 1. Approved the change in designation of Mr. Dewansh Ajay Vasani (DIN: 08111804), from Non-Executive Director to Executive Director and fix his remuneration.
• 1. Approved the resignation of Mr. Prataprai Panachand Gandhi (DIN: 07832673) from the Directorship of the Company.

Kindly take the above on records.

Thanking you.

Yours faithfully, For Vaishali Pharma Limited

Akshay Thorskhould

Akshay Jharkhandi Company Secretary & Compliance Officer

Page 2 of 2